Skip to main content

Want a detailed portfolio tracker?

Rapport Therapeutics (RAPP) P/E (2024 - 2026)

Rapport Therapeutics (RAPP) P/E from Jul 1, 2024 to Jul 21, 2026. The TTM Rapport Therapeutics (RAPP) P/E is -17.59. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Rapport Therapeutics (RAPP)

YearP/EChange
2026-17.59+54.41%
2025-11.39-2.32%
2024-11.66N/A

Comparison Rapport Therapeutics (RAPP) P/E with competitors

Rapport Therapeutics (RAPP) P/E is -17.59.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.43%
FGENFibroGen Inc0.24-101.36%
CHRSCoherus Biosciences Inc0.85-104.82%
FBIOFortress Biotech Inc0.95-105.39%
ORMPOramed Pharmaceuticals Inc1.50-108.54%
AGENAgenus Inc3.01-117.11%
INVAInnoviva Inc3.15-117.93%
VXRTVaxart Inc3.55-120.18%
CRMDCorMedix Inc3.63-120.63%
CVACCureVac N.V.4.45-125.27%
GLPGGalapagos NV4.86-127.62%
SRPTSarepta Therapeutics Inc4.88-127.75%
ABEOAbeona Therapeutics Inc5.39-130.63%
ABUSArbutus Biopharma Corp5.60-131.81%
ZVRAZevra Therapeutics Inc5.89-133.47%
SPROSpero Therapeutics Inc6.23-135.41%
CGENCompugen Ltd6.31-135.89%
RIGLRigel Pharmaceuticals6.87-139.06%
SLXNSilexion Therapeutics Corp7.30-141.47%
OMEROmeros Corporation9.26-152.63%
AUPHAurinia Pharmaceuticals Inc9.58-154.49%
PLXProtalix BioTherapeutics Inc10.89-161.91%
ACADAcadia Pharmaceuticals Inc11.73-166.67%
TBPHTheravance Biopharma Inc12.26-169.70%
ADMAAdma Biologics Inc12.42-170.59%
HRMYHarmony Biosciences Holdings Inc13.82-178.56%
SABSSAB Biotherapeutics Inc14.14-180.36%
NAGENiagen Bioscience Inc14.82-184.23%
INCYIncyte Corp15.82-189.94%
REGNRegeneron Pharmaceuticals Inc15.86-190.14%
PBYIPuma Biotechnology Inc17.32-198.43%
CPRXCatalyst Pharmaceuticals Inc17.44-199.13%
EXELExelixis Inc17.54-199.70%
TGTXTG Therapeutics Inc18.97-207.81%
MDXGMimedx Group Inc20.55-216.83%
XOMAXOMA Royalty Corp22.87-230.04%
ARGXArgen X SE24.30-238.13%
CTMXCytomX Therapeutics Inc24.82-241.10%
XOMAOXOMA Royalty Corp25.34-244.08%
HALOHalozyme Therapeutics Inc25.62-245.66%
XOMAPXOMA Royalty Corp25.67-245.93%
VRTXVertex Pharmaceuticals Inc27.99-259.14%
RPRXRoyalty Pharma plc - Class A28.69-263.08%
SLNOSoleno Therapeutics Inc29.02-264.94%
ASNDAscendis Pharma A/S30.09-271.03%
LGNDLigand Pharmaceuticals Inc - Class B37.91-315.52%
APLSApellis Pharmaceuticals Inc39.02-321.82%
BMRNBiomarin Pharmaceutical Inc42.21-339.96%
KRYSKrystal Biotech Inc45.34-357.76%
ONCBeiGene Ltd69.54-495.32%
PHARPharming Group N.V.75.03-526.50%
TECHBio-Techne Corp101.96-679.60%
VCELVericel Corp109.92-724.87%
ALNYAlnylam Pharmaceuticals Inc117.96-770.60%
GMABGenmab140.29-897.51%
TLXTelix Pharmaceuticals Ltd162.15-1021.79%
CORTCorcept Therapeutics Inc212.86-1310.03%